Green Zebras S.A.

Research and experimental development in natural sciences and engineering

KRS: NIP: REGON:

Overview

Status
Active
Registry date
2022-12-22
Share capital
165,781.80 PLN
Average employment (FTE)
9.3 (2025)
Activity description

Green Zebras is a technology company that develops formulations for functional food and active substance feed additives, leveraging its experience in human food products for the veterinary sector. The company is currently expanding its research and development activities in pharmaceutical veterinary medicine, seeking new candidates for companion animal medications. Their team collaborates with specialists in human and veterinary drug development, preclinical pharmacology, and in vivo studies.

Registered address
ul. Eugeniusza Kwiatkowskiego 4, 52-326 Wrocław, Poland
Phone
Social media
Electronic delivery address
AE:PL-47767-44716-CHACI-24

Financials

Revenue history (in k)

Financial insight

  • The statement flags a going concern risk. Szczegółowy opis okoliczności wskazujących na zagrożenie kontynuowania działalności zamieszczono w załączniku Informacje dodatkowe w punkcie 9. Informacje dotyczące kontynuowania działalności.

From the notes

Current income tax (CIT due)$0
Profit allocationLoss to be covered
Loans and borrowings$43,413
Capital expenditure$24,274
Foreign sales6.36% of revenue ($20,166)
Receivables write-downs$2,522

Filing timeliness

Financial statements were filed on time, on average 31 days early. All were audited by a statutory auditor.

  • 202503/07/2026
  • 202417/04/2025
  • 202302/07/2024
  • 202204/07/2023
Filed on timeDelayFiling deadline

Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.

Stock quotes

PLN 8.65
-0.55 (-5.98%)
9.009.508.6510:0012:0014:0016:00
Open
PLN 9.60
High
PLN 9.60
Low
PLN 8.65
Volume
2.81K
Avg. vol.
408.2
Market cap
PLN 13.72M
P/E ratio
–
EPS
-PLN 1.29
Shares outstanding
1.59M
52-week
PLN 8.65 – 10.40
Dividend yield
–
Dividend
–
Ex dividend date
–
Exchange
NewConnect

Quarterly results

PeriodRevenueEBITNet profit
Q3 2026USD 0.00USD -119.39kUSD -121.29k
Q2 2026USD 4.86kUSD -201.78kUSD -202.05k
Q1 2026USD 80.23kUSD -111.02kUSD -113.72k
Q4 2025USD 67.30kUSD -126.82kUSD -128.83k

Statistics

How the company ranks by revenue within its industry, city, voivodeship and across Poland in 2025.

Top 35%
Top 33%
City · Wrocław5,888 / 13,650
Top 43%
Voivodeship · Dolnośląskie11,181 / 23,831
Top 47%
Country · Poland142,473 / 297,069
Top 48%

Results vs industry

Revenue
This companyUSD 328.66kMedianUSD 153.26kAverageUSD 4.77m
Net profit
This companyUSD -437.38kMedianUSD -293.45AverageUSD 306.55k
Operating costs
This companyUSD 745.09kMedianUSD 188.47kAverageUSD 4.59m
Assets
This companyUSD 692.18kMedianUSD 281.58kAverageUSD 8.35m

Trademarks

The company holds 1 active trademark registered with the Polish Patent Office. The first mark was filed in 2023.

MarkNumberClassesStatusProtected until
VERY CALM ZEBRA Z.56257232Protected Nov 13, 2033
MarkProtected until
VERY CALM ZEBRA Nov 13, 2033

Authorized Representatives

Ewelina Agnieszka Pawlus-Czerniejewska age 39 – President of the Management Board
Paweł Wielgus age 46 – Management Board Member

Manner of representation

The company is represented by each member of the management board independently.

Supervisory board

Andrij Włach age 43 – Supervisory Board Member
Łukasz Piotr Bzdzion age 44 – Supervisory Board Member
Michał Maciej Chruścicki age 41 – Supervisory Board Member
Ewa Więcławik age 35 – Supervisory Board Member
Wiesław Oleszek age 78 – Supervisory Board Member

Bank accounts

Registered as a VAT taxpayer on 2020-04-23.

Debt

No entries in the National Debtors Register (KRZ).

Real estate

TypeAmount
Buildings and premises
PLN 57,154

MSiG notices

Publication dateEvent
Dec 11, 2023Commercial Companies Code notice
Nov 10, 2023Bankruptcy notice
Oct 18, 2023Shareholders' meeting convened

Public aid

7 public aid cases recorded, with a total value of $45,106.

PurposeGross amount
De minimis aid (in accordance with Commission Regulation 2023/2831)
–
De minimis aid (in accordance with Commission Regulation 2023/2831)
–
De minimis aid (in accordance with Commission Regulation No 1407/2013 or earlier)
–

Regulatory authorisations

AuthorityTypeStatus
BDO register entry Active

Competitors

Name
Pikralida sp. z o.o.
Medicofarma Biotech S.A.
Globe Badania Kliniczne sp. z o.o.
F1 Pharma S.A.
Bioscientia sp. z o.o.
Pharma Trend sp. z o.o.
TCI sp. z o.o.
Countess Laboratories sp. z o.o.
Ti-Com sp. z o.o.
SN Biotech Technologies sp. z o.o. + limited partnership

Change history

DateEvent
2026-09-02Share capital increase
2025-11-21Share capital increase
2024-12-24PKD change
2024-02-02Share capital increase
2023-10-09Share capital increase

FAQ

Last updated: 2026-09-02